Navigation Links
Studies Investigate New Methodologies to Improve Recovery and Survival Strategies for Patients Undergoing Hematopoietic Cell Transplantation
Date:12/10/2011

demonstrated recently by using a less aggressive, non-myeloablative preparative regimen, followed by an infusion of unmanipulated bone marrow and the post-transplant use of a common chemotherapy drug, cyclophosphamide (Cy), but relapse is relatively common, especially in those with high-risk myeloid malignancies. This study sought to determine whether it is possible to decrease the probability of relapse in these high-risk patients by using a myeloablative preparative regimen with PBSCs, instead of bone marrow, as the graft source.

Between January 2009 and March 2011, the investigators initiated a clinical trial enrolling 20 patients with high-risk blood cancers, including leukemia and both Hodgkin and non-Hodgkin lymphoma, undergoing haploidentical HCT. Participants were eligible for the trial if they were perceived to be at a high risk of relapse using a less aggressive preparative regimen following transplantation. Eleven patients (55%) had relapsed or refractory disease, while the remaining nine patients (45%) had standard-risk disease, the majority being leukemia patients in remission but associated with poor-risk features. After the administration of the myeloablative preparative regimen, patients underwent transplantation with PBSCs, followed by an immunosuppressive regimen of Cy (50mg/kg/day) on days three and four post transplant along with other supportive therapies.

After an average follow-up of 14 months, investigators reported an estimated one-year overall survival rate of 74 percent and a disease-free survival (DFS) rate of 51 percent for all patients; for standard risk patients, one year overall survival was 100 percent and DFS was 76 percent. Non-relapse mortality at 100 days and 12 months was 10 percent for all patients and zero for standard risk patients. The cumulative incidence of chronic GVHD at one year was 42 percent.

Non-infectious fever developed in 90 percent of patients within a median of 2.5 days of transplant and w
'/>"/>

SOURCE American Society of Hematology
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Bayers Drospirenone-containing Combination Oral Contraceptives: FDA Advisory Committees Affirm Positive Benefit-risk Profile and Recommend an Update of Labels to Reflect Information From Available Studies
2. Genomic Health Announces Presentation of Sixteen Oncotype DX Studies at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
3. Montage Announces Three More Hospitals Implement Their On-Demand Search and Data Mining Technology for Radiology Studies
4. Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types
5. Isis Initiates Phase 1 Studies with Isis-GCGRRx and Isis-GCCRRx to Treat Type 2 Diabetes
6. Data From Phase 2 Clinical Studies of Telotristat Etiprate in Patients With Carcinoid Syndrome to be Presented at North American Neuroendocrine Tumor Society Meeting
7. New Clinical Studies Presented at the American Society of Anesthesiologists Annual Meeting Show Benefits of Masimo Noninvasive Technologies: SpHb, PVI, RRa, and SEDLine
8. Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
9. Managing Bioequivalence Studies to Optimize the Quality, Cost, and Speed of Generics Manufacturing
10. FDA Seeks Comment on Proposed Guidelines for High-Quality Clinical Studies
11. Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015  Omeros Corporation (NASDAQ: OMER ) today ... Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, ... the District of New Jersey ... of Delaware . The lawsuits were ... three Omeros patents, U.S. Patent Nos. 8,173,707, 8,586,633 and ...
(Date:9/3/2015)... Sep. 03, 2015 ... announced the addition of the "Investigation ... report to their offering. Non-steroidal ... chemical structure from steroids which have a ... provide analgestic and antipyretic effects with fewer ...
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... announced the addition of the "Investigation Report on ... Oxiracetam, a derivative of pyrrolidone, was first ... drug whose oral preparation and injection entered the Italian ... develops fast after entering China , ...
Breaking Medicine Technology:Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4China Flurbiprofen Market Investigation Report 2010-2019 2Investigation Report on China's Oxiracetam Market, 2010-2019 2
... April 21 Each year, the Food and Drug Administration (FDA) approves many ... , , ... , , This FDA ... October 2009 . , , , ...
... To enhance patient care management, Kaweah ... the wireless Draeger Infinity M300 patient-worn (telemetry) monitor. This ... both at the patient site and the central nursing ... achieve the best patient outcomes. Two-way communication with the ...
Cached Medicine Technology:FDA Consumer Health Information - Generic Drug Roundup: April 2010 2Draeger Infinity M300 Patient-Worn Monitors Help Improve Patient Care at Kaweah Delta Medical Center 2Draeger Infinity M300 Patient-Worn Monitors Help Improve Patient Care at Kaweah Delta Medical Center 3Draeger Infinity M300 Patient-Worn Monitors Help Improve Patient Care at Kaweah Delta Medical Center 4
(Date:9/3/2015)... ... September 03, 2015 , ... ... Companies to Watch for 2015 by economic development group GrowFL and the ... companies in the state selected for this prestigious award, which recognizes growing second-stage ...
(Date:9/3/2015)... ... 03, 2015 , ... The first part of a two-part investigative news segment ... filter lawsuits filed against Bard.** These lawsuits, filed by persons and the family ... or failed, have recently been consolidated for pretrial proceedings as multidistrict litigation, MDL 2641 ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... to healthcare providers, has been retained to lead a national chief executive ... top executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:9/3/2015)... DC (PRWEB) , ... September 03, 2015 , ... ... the speakers for its upcoming virtual conference, “Proven Pharmacy Benefit Strategies for a ... such as CVS Health, Express Scripts and Milliman, will discuss how plan sponsors ...
(Date:9/3/2015)... ... September 03, 2015 , ... “We wish to become known ... delicate life balance between work and leisure to the benefit of every consumer ... , A LifeMinder Plus® Emergency Care Document Set duly executed set ensures that ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3
... any other name is still a rose, but is ... and ,jock, are sometimes used interchangeably, but they are ... at Buffalo researcher Kathleen E. Miller, Ph.D. "In terms ... norms, these two identities represent very different perspectives and ...
... About Teamwork During the Games , , DALLAS, June 1 ... take the field in Oklahoma City. The 2009 NCAA Division I Women,s ... ASA Hall of Fame Stadium, and AT&T* and the NCAA will be ... Boys & Girls Club. , , The opening game will be ...
... Roshan, Cisco, the Government of Afghanistan, The Aga Khan ... or Children, Aga Khan Health Services and the ... Linking Afghan Hospitals to International Medical Institutions , ... Roshan, the leading telecom operator in Afghanistan, ...
... Photo Contest to Celebrate National Dairy & Smile Month , ... and child starts at sundown. Bath: Check. Pajamas on: ... Suddenly, the nightly routine can come to a screeching ... to a 2006 report by the Dental Health Foundation, by the ...
... , Annual Award for outstanding contributions in the field ... Diehl during the annual conference of the National Association ... GARDENS, Fla., June 1 The recently held National ... Palm Beach Gardens, FL was the occasion where the ...
... Continuing Education Lectures for Healthcare Professionals , , ... challenging diagnosis which carries a poor prognosis and appears ... signaling and tumor suppressor pathways. While current treatment options ... for patients. In order to do this, healthcare professionals ...
Cached Medicine News:Health News:Don't mistake an athlete for a 'toxic jock' 2Health News:AT&T Shares 2009 NCAA Women's College World Series With American Cancer Society and Boys & Girls Club 2Health News:Roshan Announces Expansion of Afghanistan's First Telemedicine Project to Bamyan Region 2Health News:Roshan Announces Expansion of Afghanistan's First Telemedicine Project to Bamyan Region 3Health News:Roshan Announces Expansion of Afghanistan's First Telemedicine Project to Bamyan Region 4Health News:Roshan Announces Expansion of Afghanistan's First Telemedicine Project to Bamyan Region 5Health News:Roshan Announces Expansion of Afghanistan's First Telemedicine Project to Bamyan Region 6Health News:Roshan Announces Expansion of Afghanistan's First Telemedicine Project to Bamyan Region 7Health News:Say Cheese With Milk 2Health News:Say Cheese With Milk 3Health News:Say Cheese With Milk 4Health News:Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators (ACATA) 2Health News:Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators (ACATA) 3Health News:Adult Glioblastoma: Best Approaches to a Challenging Diagnosis 2
... OB/GYN, ER/Trauma, ICC/CCU, woundcare and burn ... precision and control, plus consistent high ... SATIN PLUS* Sterile Singles deliver all ... provides excellent tactile sensitivity. The gloves ...
... Soft translucent material for ... finger cot with additional ... Full-width 50mm adhesive strip ... finger lift for easy ...
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification...
... IV and the Penilab V have an exceptionally sensitive ... is similar to the Model 1061 shown below, but ... added later. The Penilab V has a Doppler. ... accessories you'll need to get started. Latex rubber ...
Medicine Products: